Global Human Chorionic Gonadotropin Market Report By Technology(Natural Source Extraction And Recombinant Technology), By Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment And Others), By End-User (Fertility Clinics, Research Institution And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210347
January 2019
Report Formats:

As per this study, the Global Human Chorionic Gonadotropin Market was valued USD 725.6 MN (by revenue) in 2018 and is anticipated to reach USD 1203.8 MN by 2025 with a CAGR of 7.5%.
 
Human chorionic gonadotropin as HCG is the placental hormone secreted by the placental cells in pregnancy immediately after implantation. HCG stimulates egg secretion during ovulation and also helps to treat infertility in female and increase sperm count in the male population. Presence of HCG is detected in urine or blood sample of pregnant female.
 
Market Dynamics
 
The rising prevalence of infertility among both female and male population is the major driver driving the market growth. Increasing cases with polycystic ovary syndrome, endometriosis, hypogonadism, oligospermia, and other hormonal disorders are further pushing the market demand. Also, changing lifestyle, improper eating habits and increased maternity age are some of the prominent factors boosting the market demand. In addition to this, increasing awareness regarding HCG hormone treatment by medical professionals is likely to upsurge the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human chorionic gonadotropin.
 
Market Segmentation
 
The broad human chorionic gonadotropin market has been sub-grouped into type, application, and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Technology

  • Natural Source Extraction
  • Recombinant Technology
 
By Therapeutic Area
  • Female Infertility Treatment
  • Male Hypogonadism
  • Oligospermic Treatment
  • Others
 
By End-User
  • Fertility Clinics
  • Research Institution
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for human chorionic gonadotropinin North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Human Chorionic Gonadotropin Market By Revenue (USD MN)
 
Europe Human Chorionic Gonadotropin Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the human chorionic gonadotropin market include Bristol Myers Squibb Company, Cigna, Ferring B.V., Fresenius Kabi AG, Lee BioSolutions, Inc., Lupin, Merck & Co., Inc., Sanzyme, Scripps Laboratories and Sun Pharmaceutical Industries Ltd. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.


METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Human Chorionic Gonadotropin
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Human Chorionic Gonadotropin Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY TECHNOLOGY
  • Market In Natural Source Extraction
  • Market In Recombinant Technology
 
5. HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY THERAPEUTIC AREA
  • Market In Female Infertility Treatment
  • Market In Male Hypogonadism
  • Market In Oligospermic Treatment
  • Market In Others
 
6. HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY END-USER
  • Market In Fertility Clinics
  • Market In Research Institution
  • Market In Others
 
7. HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE HUMAN CHORIONIC GONADOTROPIN COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE HUMAN CHORIONIC GONADOTROPIN INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Bristol Myers Squibb Company
  • Cigna
  • Ferring B.V.
  • Fresenius Kabi AG
  • Lee BioSolutions, Inc.
  • Lupin
  • Merck & Co., Inc.
  • Sanzyme
  • Scripps Laboratories
  • Sun Pharmaceutical Industries Ltd.
 
* Tentative TOC 
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Human Chorionic Gonadotropin
Table 2.  Global Human Chorionic Gonadotropin Market By Technology
Table 3.  Global Human Chorionic Gonadotropin Market By Therapeutic Area
Table 4.  Global Human Chorionic Gonadotropin Market By End-User
Table 5.  Global Human Chorionic Gonadotropin Market By Geography
Table 6.  North America Human Chorionic Gonadotropin Market
Table 7.  Europe Human Chorionic Gonadotropin Market
Table 8.  Asia Pacific Human Chorionic Gonadotropin Market
Table 9.  Latin America Human Chorionic Gonadotropin Market
Table 10. Middle East And Africa Human Chorionic Gonadotropin Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
  
LIST OF FIGURES 
 
Fig. 1.     Market Segmentation Of Human Chorionic Gonadotropin Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Human Chorionic Gonadotropin
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Human Chorionic Gonadotropin Market By Technology
Fig. 8.     Global Human Chorionic Gonadotropin Market By Therapeutic Area
Fig. 9.     Global Human Chorionic Gonadotropin Market By End-User
Fig. 10.   Global Human Chorionic Gonadotropin Market By Geography
Fig. 11.   North America Human Chorionic Gonadotropin Market
Fig. 12.   Europe Human Chorionic Gonadotropin Market
Fig. 13.   Asia Pacific Human Chorionic Gonadotropin Market
Fig. 14.   Latin America Human Chorionic Gonadotropin Market
Fig. 15.   Middle East And Africa Human Chorionic Gonadotropin Market
Fig. 16.   Market Share Of Human Chorionic Gonadotropin Companies
Fig. 17.   Recent Developments In Human Chorionic Gonadotropin Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials